Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Burden and Outcomes of Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections (MBI-LCBI) in the First 100 Days after Allogeneic Stem Cell Transplant: A CIBMTR Analysis

Christopher E Dandoy, MD MS, Min Chen, MS, Soyoung Kim, Krishna Komanduri, MD, Caroline A. Lindemans, MD, Miguel-Angel Perales, MD, Marcie L. Riches, MDMS

Blood (2018) 132 (Supplement 1): 3375.

https://doi.org/10.1182/blood-2018-99-114629

Published: 2018

Journal Articles

Regulatory T Cells Expanded Via TL1A-Ig Fusion Protein and Low Dose IL-2 Demonstrate Potent Suppression of Graft-Versus-Host Disease

Sabrina Copsel, PhD, Dietlinde Wolf, PhD, Brandon Kale, Henry Barreras, MPH, Casey O. Lightbourn, MS, Cameron S. Bader, BS, Krishna Komanduri, MD, Robert B. Levy, PhD

Blood (2017) 130 (Supplement 1): 4434.

https://doi.org/10.1182/blood.V130.Suppl_1.4434.4434

Published: 2017

Journal Articles

Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States

Luis E Malpica Castillo, MD, Agustin Pimentel, MD, Isildinha M Reis, PhD, Eduardo Gotuzzo, MD, Lazaros J. Lekakis, MD, Krishna Komanduri, MD, Thomas J. Harrington, MD, Glen N. Barber, PhD, Juan Carlos Ramos, MD BS

Blood (2017) 130 (Supplement 1): 373.

https://doi.org/10.1182/blood.V130.Suppl_1.373.373

Published: 2017

Journal Articles

Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

Jose F Camargo, MD, Eric Wieder, PhD, Erik Kimble, MD, Cara Benjamin, PhD, Despina Kolonias, Gabriela Bravo, MD, Krishna Komanduri, MD

Blood (2017) 130 (Supplement 1): 746.

https://doi.org/10.1182/blood.V130.Suppl_1.746.746

Published: 2017

Journal Articles

Demonstration of a Direct Immunomodulatory Role for Vitamin D in Human T Cells Using Flow Cytometry

Richard W. Joseph, Jr., MD, Tae Kon Kim, Lisa St. John, Jahan Khalili, Uday R Popat, Richard E Champlin, MD, Jeffrey J. Molldrem, M.D., Eric Wieder, Ph.D, Krishna Komanduri, MD

Blood (2008) 112 (11): 2577.

https://doi.org/10.1182/blood.V112.11.2577.2577

Published: 2008

Journal Articles

PR1 Peptide Vaccine-Induced Immune Response Is Associated with Better Event-Free Survival in Patients with Myeloid Leukemia.

Muzaffar H. Qazilbash, MD, Eric D. Wieder, PhD., Peter F. Thall, PhD, MS, BS, Xuemei Wang, MS, Rosa L. Rios, ADN, Sijie Lu, PhD, Shreya Kant, PhD, Sergio Giralt, MD, Elihu H. Estey, MD, Jorge Cortes, MD, Krishna Komanduri, MD, Richard E. Champlin, MD, Jeffrey J. Molldrem, MD

Blood (2007) 110 (11): 283.

https://doi.org/10.1182/blood.V110.11.283.283

Published: 2007

Journal Articles

PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival.

Muzaffar H. Qazilbash, MD, Eric D. Wieder, PhD, Peter F. Thall, PhD, MS, BS, Xuemei Wang, MS, Rosa L. Rios, Sijie Lu, PhD, Shreya Kant, PhD, Sergio A. Giralt, MD, Elihu H. Estey, MD, Jorge Cortes, MD, Krishna Komanduri, MD, Richard E. Champlin, MD, Jeffrey J. Molldrem, MD

Blood (2007) 110 (11): 577.

https://doi.org/10.1182/blood.V110.11.577.577

Published: 2007

Journal Articles

Maintenance Therapy with 5-Azacytidine (5-AC) after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): A Dose and Schedule Finding Study.

Andres O. Soriano, MD, Richard Champlin, MD, Gloria McCormick, Sergio Giralt, MD, Peter Thall, PhD, Krishna Komanduri, MD, Muzaffar Qazilbash, MD, Guillermo Garcia-Manero, MD, Marcos De Lima, MD

Blood (2006) 108 (11): 3668.

https://doi.org/10.1182/blood.V108.11.3668.3668

Published: 2006

Journal Articles

Vaccination with the PR1 Leukemia-Associated Antigen Can Induce Complete Remission in Patients with Myeloid Leukemia.

Muzaffar H. Qazilbash, MD, Eric Wieder, PhD, Rosa Rios, Sijie Lu, Shreya Kant, Sergio Giralt, MD, Elihu H. Estey, MD, Peter Thall, Marcos de Lima, MD, Daniel Couriel, MD, Richard E. Champlin, MD, Krishna Komanduri, MD, Jeffrey J. Molldrem, MD

Blood (2004) 104 (11): 259.

https://doi.org/10.1182/blood.V104.11.259.259

Published: 2004

NARROW

Burden and Outcomes of Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections (MBI-LCBI) in the First 100 Days after Allogeneic Stem Cell Transplant: A CIBMTR Analysis

Regulatory T Cells Expanded Via TL1A-Ig Fusion Protein and Low Dose IL-2 Demonstrate Potent Suppression of Graft-Versus-Host Disease

Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States

Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

Demonstration of a Direct Immunomodulatory Role for Vitamin D in Human T Cells Using Flow Cytometry

PR1 Peptide Vaccine-Induced Immune Response Is Associated with Better Event-Free Survival in Patients with Myeloid Leukemia.

PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival.

Maintenance Therapy with 5-Azacytidine (5-AC) after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): A Dose and Schedule Finding Study.

Vaccination with the PR1 Leukemia-Associated Antigen Can Induce Complete Remission in Patients with Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only